Merck KGaA Moves Neurobion, Floratil Brands To Consumer Division
This article was originally published in The Tan Sheet
Executive Summary
As of Jan. 1, the German firm moved Neurobion products, marketed globally, and the Floratil line sold in Brazil from Merck Serono to its Consumer Health division. The firm’s 2013 fourth quarter OTC and nutritional product sales were flat at $655 million